FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称BICTEGRAVIR SODIUM
异名/同义词(2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE MONOSODIUM SALT
2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE, 2,3,4,5,7,9,13,13A-OCTAHYDRO-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-, SODIUM SALT (1:1), (2R,5S,13AR)-
BICTEGRAVIR SODIUM
BICTEGRAVIR SODIUM [JAN]
BICTEGRAVIR SODIUM [MI]
BICTEGRAVIR SODIUM [ORANGE BOOK]
BIKTARVY COMPONENT BICTEGRAVIR SODIUM
GS-9883 SODIUM
GS-9883-01 SODIUM
BICTEGRAVIR SODIUM [USAN]
BICTEGRAVIR SODIUM [WHO-DD]
CAS登记号1807988-02-8
物质唯一标识(Unique Ingredient Identifier)4L5MP1Y7W7
分子式C21H17F3N3O5.Na
国际化合物标识(International Chemical Identifier,InChI)WJNFBIVCQMPPJC-FQYDJHLKSA-M
SMILES[C@@]12(N(C(c3n(C1)cc(c(c3[O-])=O)C(NCc4c(cc(cc4F)F)F)=O)=O)[C@H]5CC[C@@H](O2)C5)[H].[Na+]
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System